IRIS
ARRU, Giannina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.899
EU - Europa 1.726
AS - Asia 799
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
Totale 5.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.887
UA - Ucraina 851
CN - Cina 753
DE - Germania 284
SE - Svezia 169
IT - Italia 162
FI - Finlandia 129
GB - Regno Unito 42
FR - Francia 39
BE - Belgio 19
IN - India 16
TR - Turchia 14
AU - Australia 11
CA - Canada 11
EU - Europa 7
IR - Iran 5
ES - Italia 4
EE - Estonia 3
HU - Ungheria 3
NL - Olanda 3
RO - Romania 3
AL - Albania 2
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
HK - Hong Kong 2
ID - Indonesia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GE - Georgia 1
IE - Irlanda 1
JP - Giappone 1
LV - Lettonia 1
ME - Montenegro 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 5.451
Salva come PNG Salva come JPEG
Città #
Chandler 694
Jacksonville 534
Princeton 285
Nanjing 237
Dearborn 228
Wilmington 126
Nanchang 90
Ann Arbor 77
Beijing 63
Ashburn 57
Hebei 51
Shenyang 49
Sassari 48
Boardman 46
New York 43
Changsha 42
Tianjin 40
Jiaxing 35
Woodbridge 27
Jinan 25
Kunming 22
Norwalk 22
Ningbo 21
Andover 20
Brussels 19
San Francisco 19
San Mateo 16
Zhengzhou 16
Hangzhou 15
Mountain View 13
Falls Church 11
Monmouth Junction 10
Guangzhou 9
Los Angeles 9
Haikou 8
Izmir 8
Toronto 8
Rome 7
Augusta 6
Leawood 6
Hefei 5
Sydney 5
Taizhou 5
Bologna 4
Changchun 4
Melbourne 4
Milan 4
Ardabil 3
Auburn Hills 3
Bellante 3
Edinburgh 3
Helsinki 3
Lanzhou 3
Macomer 3
Madrid 3
Nuoro 3
Oristano 3
Paris 3
Syracuse 3
Tallinn 3
Vélizy 3
Amsterdam 2
Brescia 2
Bucharest 2
Budapest 2
Casavatore 2
Chisinau 2
Civitavecchia 2
Clearwater 2
Corciano 2
Delhi 2
Hanover 2
Houston 2
Hyderabad 2
Lonato 2
London 2
Markham 2
Montebelluna 2
Shaoxing 2
St Louis 2
Tirana 2
Turin 2
Zurich 2
Alghero 1
Almere Stad 1
Atlanta 1
Auckland 1
Austin 1
Blountville 1
Bogotá 1
Büdelsdorf 1
Cagliari 1
Canberra 1
Cardiff 1
Casalecchio di Reno 1
Catanzaro 1
Chengdu 1
Chicago 1
Chittagong 1
Dover 1
Totale 3.196
Salva come PNG Salva come JPEG
Nome #
Rilevazione differenziale di MSRV e sincitina nel RNA e DNA di pazienti con sclerosi multipla 99
Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden 79
JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab 77
Novel reliable real-time PCR for differential detection of MSRVenv and Syncytin-1 in RNA and DNA from patients with multiple sclerosis 73
Characterisation of an HIV-1 strain with preferential replication in adherent cells 70
Serum uric acid and multiple sclerosis 66
Optic neuritis and conversion to definite MS: comparison between MS-associated retrovirus and other prognostic markers 66
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis 65
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 61
Unequivocal linkage to multiple sclerosis of the MS-associated retrovirus in distinct European populations 60
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase 60
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1 57
Extracellular release of the HERV-W Multiple sclerosis-associated retrovirus (MSRV) and its regulation by cytokines and HIV 57
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase. 57
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 56
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 55
Multiple sclerosis: peripheral mononuclear cells inhibit Plasmodium falciparum growth and are activated by parasite antigens 54
In vitro modulation of dendritic cells and lymphocytes by glatiramer acetate. Implications for multiple sclerosis treatment 54
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients 54
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outccome in a Swedish cohort 54
Expression of human endogenous retroviruses in multiple sclerosis brain and glial cell cultures 53
Inflammatory biomarkers in blood of patients with acute brain ischemia 53
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 53
Multiple sclerosis and hygiene hypothesis: reduced Toll-like receptor 9 expression in MS in response to P. falciparum 51
A possible prognostic role for MSRV in multiple sclerosis. 51
Anti-Inflammatory Liver X Receptors and Related Molecules in Multiple Sclerosis Patients from Sardinia and Sweden 51
Multiple sclerosis and chitotriosidase: a novel association 51
Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis 50
Glatiramer acetate inhibits dendritic cells capability to stimulate lymphocytes proliferation 50
Multiple sclerosis-associated retrovirus and MS prognosis: an observational study 49
Il retrovirus HERV-W associato alla sclerosi multipla (MSRV) viene rilasciato da linfociti di soggetti portatori ed è sensibile a citochine e HIV 49
Intrathecal chitotriosidase and the outcome of multiple sclerosis 49
VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology 49
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 49
Constitutive Expression of human endogenous retroviruses in normal and multiple sclerosis brains and glial cell cultures 49
A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder 47
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease 46
Chitotriosidase in patients with acute ischemic stroke 46
Chitotriosidase and Alzheimer's disease 45
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease? 45
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 45
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: Implications for MS pathogenesis 44
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease? 44
Circulating Multiple Sclerosis (MS)-associated retrovirus (MSRV) correlates with MS, is increased in vitro by proinflammatory and inhibited by interferon beta both in vitro and in vivo 44
Fucosyl-oligosaccharides decrease mononuclear cells in vitro activation, particularly in multiple sclerosis 43
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients 43
In vitro release and modulation of Multiple Sclerosis-Associated HERV-W Retrovirus by peripheral blood mononuclear cells from virus-positive subjects. 43
Quantitative and qualitative RT-PCR detection of the multiple sclerosis (MS)-associated retrovirus in populations of different ethnicity 42
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6 42
Chitotriosidase in multiple sclerosis 42
Il-2 and mycobacterial lipoarabinomannan as targets of immune responses in multiple sclerosis patients 42
Multiple sclerosis in Sardinia: Reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 by pDC in response to herpes simplex virus type 1 42
Viral infection in multiple sclerosis is associated with low proportion of plasmacytoid dendritic cells and low production of the protective cytokines IL-6 and IL-10 42
Constitutive Expression of human endogenous retroviruses in Normal and multiple sclerosis brains and glial cell cultures 41
Acute brain ischemia and inflammation. An outcome study 41
MSRV/HERV-W and Sardinian Multiple Sclerosis 41
Absence of correlation between expression of the multiple sclerosis-associated retrovirus (MSRV)/ERV-W in MS patients and controls and presence of human herpesvirus-6 41
Possible selection of a Sardinian variant of the Multiple Sclerosis-Associated Retrovirus. 41
Seroprevalence of Hepatitis B Virus Markers in a Cohort Of Sardinian Patients With Multiple Sclerosis. 41
Multiple sclerosis and anti-Plasmodium falciparum innate immune response 40
Multiple sclerosis prognosis. A possible role for MSRV 40
Anti-inflammatory liver x receptors and related molecules in multiple sclerosis patients from Sardinia and Sweden 40
Effetti Contrastanti da Interferon-γ dei due principali corecettori per HIV e vantaggio selettivo per il legame di HIV-M tropico a cellule aderenti 40
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 40
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. 40
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients 40
MS-associated retrovirus in optic neuritis and non-inflammatory controls: a prevalence study in a Swedish population 39
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outcome in a Swedish cohort 39
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 39
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 39
Multiple sclerosis (MS) associated retrovirus (MSRV) in patients with monosymptomatic optic neuritis: comparison to other prognostic markers in Swedish patients 38
Characterization of an HIV type 1 strain with preferential replication in adherent cells 38
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outccome in a Swedish cohort 38
Copolymer-1 modulation of dendritic cells-mediated lymphocytes proliferation is restricted to multiple sclerosis 38
Multiple sclerosis: dendritic cells and lymphocytes are modulated by Glatiramer acetatein vitro 38
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects. 38
Human endogenous retroviruses in glial cell cultures and brain tissues. Further evidences for their role in multiple sclerosis 38
The MSRV/HERV-W env protein is expressed in brain lesion of MS patients and not in normal-apparing control brains 37
Deficiency of BDCA2+ and BDCA4+ cells in multiple sclerosis. 36
Detection of MSRV in MS patients from different European populations and in relation to clinical activity 36
Selezione di una variante Sarda del retrovirus associato alla Sclerosi multipla (MSRV) e sua modulazione e rilascio in vitro da PBMC di soggetti virus positivi 36
RE: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]. 36
La Proteina env di HERV-W/MSRV è espresso nelle lesioni cerebrali di pazienti SM ma non nei controlli sani 35
Presenza del MSRV (multiple sclerosis-associated retrovirus) in pazienti MS e controlli di etnia sarda: possibile ruolo patogenetico e caratterizzazione molecolare 35
Multiple sclerosis. (MS)-associated HERV-W retrovirus in the CSF and MS course. Results from a 3-years follow-up 34
Seasonal fluctuation of multiple sclerosis births in Sardinia 34
MSRV (Multiple sclerosis(MS)-associated retrovirus) circolante correla in vivo con la malattia; il virus è stimolato da citochine proinfiammatorie in vitro ed è inibito da interferon beta sia in vitro che in vivo 33
Multiple sclerosis-associated retrovirus and IFN therapy: a correlation study 32
Association between lipoprotein levels and humoral reactivity to mycobacterium avium subsp. Paratuberculosis in multiple sclerosis, type 1 diabetes mellitus and rheumatoid arthritis 32
Multiple sclerosis, malaria and the “hygiene hypothesis” in Sardinia 31
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. 31
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 31
Expression and regulation by cytokines of Multiple Sclerosis (MS)-associated retrovirus (MSRV), in vitro and in vivo 30
Genes, environment, and susceptibility to multiple sclerosis 30
Multiple Sclerosis and HERV-W/MSRV: A multicentric Study 30
Human Endogenous Retroviral Particles In MS Samples From Different European Ms Populations and in Relation To Clinical Activity 30
Copolymer-1 modulation of dendritic cells-mediated lymphocytes proliferation is restricted to multiple sclerosis 29
Optic neuritis and conversion to definite multiple sclerosis: comparison between MS-associated retrovirus and other prognostic markers. 29
Multiple sclerosis. (MS)-associated HERV-W retrovirus in the CSF and MS course. Results from a 3-years follow-up 29
Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis 29
Totale 4.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 0 0 107
2019/20201.439 375 2 130 3 136 210 231 16 150 39 144 3
2020/20211.050 137 3 172 5 140 38 141 6 150 162 75 21
2021/2022615 78 4 3 4 5 7 33 50 56 30 71 274
2022/20231.351 146 77 24 219 137 220 1 161 263 7 60 36
2023/2024316 72 34 14 9 68 32 37 21 2 27 0 0
Totale 5.558